3-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-benzenesulfonamide

A synthetic small molecule belonging to the hypoxanthine class of purine derivatives. It is an experimental compound with a molecular formula C18H22N6O3S and a molecular weight of approximately 402.5 g/mol. The compound has been studied as a potential inhibitor of cyclin-dependent kinase 2 (CDK2), which plays a key role in cell cycle regulation by controlling the transition from G1 to S phase. Inhibition of CDK2 is being explored for anticancer applications, but this specific molecule has not advanced beyond preclinical or early-stage research and is not approved for any indication.[1][2][6]

Other names

3-{[6-(cyclohexylmethoxy)-9H-purin-2-yl]amino}benzene-1-sulfonamide3-{[6-(cyclohexylmethoxy)-3H-purin-2-yl]amino}benzene-sulfonamide3-{[6-(cyclohexylméthoxy)-3H-purin-2-y1]amino}benzènesulfonamidebenzenesulfonamide, 3-[[6-(cyclohexylmethoxy)-7H-purin–2–y1]amino]